Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - MEDTOX SCIENTIFIC INC | ex99-1101311.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 13, 2011
MEDTOX SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
1-11394
|
95-3863205
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
402 West County Road D, St. Paul, Minnesota
|
55112
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (651) 636-7466
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02. Results of Operations and Financial Condition
On October 13, 2011, MEDTOX Scientific, Inc. announced results for the third quarter ended September 30, 2011, as described in the press release attached as Exhibit 99.1.
- 2 -
Item 9.01. Financial Statements and Exhibits.
|
(c)
|
Exhibits.
|
The following exhibit is filed as part of this report:
|
Exhibit No.
|
Description
|
|
|
99.1
|
MEDTOX Scientific, Inc. Press Release, dated October 13, 2011.
|
- 3 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDTOX Scientific, Inc.
Date: October 13, 2011 By: /s/ Richard J. Braun
Name: Richard J. Braun
Title: Chief Executive Officer
- 4 -
INDEX TO EXHIBITS
|
Exhibit No.
|
Description
|
|
|
99.1
|
MEDTOX Scientific, Inc. Press Release, dated October 13, 2011.
|
- 5 -